Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Akoya Biosciences Inc (NASDAQ: AKYA) closed at $1.14 down -8.80% from its previous closing price of $1.25. In other words, the price has decreased by -$8.80 from its previous closing price. On the day, 0.55 million shares were traded.
Ratios:
For a deeper understanding of Akoya Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.40 and its Current Ratio is at 0.61.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Craig Hallum on November 15, 2024, Downgraded its rating to Hold and sets its target price to $5 from $7 previously.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 11 ’24 when McKelligon Brian sold 7,500 shares for $2.08 per share. The transaction valued at 15,630 led to the insider holds 224,733 shares of the business.
McKelligon Brian sold 7,500 shares of AKYA for $15,064 on Jun 06 ’24. The President and CEO now owns 224,733 shares after completing the transaction at $2.01 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.71.
Stock Price History:
Over the past 52 weeks, AKYA has reached a high of $3.42, while it has fallen to a 52-week low of $0.93. The 50-Day Moving Average of the stock is -6.63%, while the 200-Day Moving Average is calculated to be -47.74%.
Shares Statistics:
A total of 49.84M shares are outstanding, with a floating share count of 20.81M. Insiders hold about 58.29% of the company’s shares, while institutions hold 24.65% stake in the company.
